Jan Aushadhi Sales to Cross Rs 2,000 Crore in FY25: PMBI CEO

By By Rediff Money Desk, New Delhi
Feb 28, 2025 16:17
Jan Aushadhi Kendras are expected to achieve sales of over Rs 2,000 crore in FY25, driven by a network of 15,000 outlets across India. Learn about the scheme's impact and future goals.
IMAGE: Kind courtesy janaushadhi.gov.in
New Delhi, Feb 28 (PTI) Sales from Jan Aushadhi Kendras are expected to cross Rs 2,000-crore mark in 2024-25, with as many as 15,000 outlets already functional across the country, the Pharmaceuticals and Medical Devices Bureau (PMBI) CEO Ravi Dadhich said on Friday.

PMBI, under the Department of Pharmaceuticals, implements Jan Aushadhi outlets under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) scheme.

Speaking to reporters here at the start of the week-long events to commemorate the Jan Aushadhi Diwas on March 7, Dadhich noted that the sales this fiscal has crossed Rs 1,750-crore mark in the ongoing fiscal.

"We aim to cross the Rs 2,000-crore sales mark this financial year. In the last decade the Jan Aushadhi outlets have led to savings of around Rs 30,000 crore for people," he noted.

From 80 outlets in 2014, the number of kendras has grown to 15,000 across the country, Dadhich stated.

"We have set a target of having 25,000 outlets by March 31, 2027. We, however, expect to cross the mark much before 2026-end," he added.

Around 2,300 medicines and surgical items are sold under the PMBJP initiative.

The products sold at the outlets are almost 50-80 per cent cheaper than branded medicines.

Jan Aushadhi Kendras also started selling sanitary pads for Re 1 each from August 27, 2019. Till now over 72 crore Janaushadhi Suvidha sanitary pads have been sold through the outlets, Dadhich said.

In order to celebrate Jan Aushadhi Diwas and spread awareness, the government plans to hold week-long events at various locations across the country.

Accordingly, Seminars , health camps, health walks and other activities will be held till March 7.
Source: PTI
Read More On:
indiasalespharmaceuticalsjan aushadhigeneric medicinesmedical devicesaffordable healthcarepradhan mantri bhartiya janaushadhi pariyojanapmbjppmbi
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

You May Like To Read

MORE NEWS

Sitharaman to Attend India-UK Economic Dialogue...

Finance Minister Nirmala Sitharaman will attend the India-UK Economic and Financial...

Mahindra Expands Design Studio for Growing...

Mahindra & Mahindra expands its Mumbai Design Studio to cater to the evolving needs of...

Sensex Crashes 2,227 Points on Trade War Fears

The Sensex plunged 2,227 points on Monday, its steepest decline in 10 months, as global...

India Steps Up Export Support Amid US Tariffs,...

India's commerce ministry is taking measures to aid exporters, including exploring new...

Adani Commences Operations at Colombo West...

Adani Ports & Special Economic Zone Ltd (APSEZ) has commenced operations at the Colombo...

Tata Motors Shares Plunge 5.5% on JLR US Tariff...

Tata Motors shares dropped 5.5% after Jaguar Land Rover suspended US shipments due to...

Pakistan Stock Exchange Plunges 8,000 Points

The Pakistan Stock Exchange (PSX) plunged over 8,000 points on Monday, fueled by fears...

CESC to Raise Rs 250 Cr via NCDs | Business News

CESC Ltd has approved a proposal to raise Rs 250 crore through issuance of Non...

Housing Sales to Rise 1-4% in FY26: ICRA

ICRA projects a modest increase in housing sales volume in FY26, with new supply...

Sensex Plunges 2,227 pts: Trade War Fears Hit...

The Sensex crashed 2,227 points, its steepest single-day fall in 10 months, as trade...

Read More »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com